Interim safety analysis of RAPPORT trial - SABR with pembrolizumab in oligometastatic RCC

S Siva, M Bressel, S Sandhu, B Tran, J Mooi, J Lewin, S Loi, G Toner, D Moon, J Goad, M Shaw, S Chander, T Eade, A Guminski, D Jayamanne, D Pryor, K Cuff, S Wood, N Lawrentschuk, D Murphy